Cadence raised $100 million in Series C funding to scale its AI-powered chronic care platform, which monitors patients at home and adjusts their medications in real time.The startup, now valued at $1.23 billion, partners with health systems to treat patients with heart failure, hypertension and diabetes.
The post Cadence Rakes In $100M to Automate Chronic Care at Scale appeared first on MedCity News.
